Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo
Our Work

Latham & Watkins Advises on Option Care Health’s Secondary Offering of Common Stock and Common Stock Repurchase

March 2, 2023
Firm represents the underwriter in the offering by the nation’s largest independent provider of home and alternate site infusion services.

Option Care Health, Inc. (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, has announced that an affiliate of Walgreens Boots Alliance, Inc. has agreed to sell 13,000,000 shares of the Company’s common stock at a price to the public of US$30.75 per share in an underwritten secondary offering. The offering is expected to close on March 3, 2023, subject to customary closing conditions. The Company will not receive any proceeds from the offering.

Latham & Watkins LLP represented the underwriter in the offering with a New York team led by capital markets partners Michael Benjamin and Adam Gelardi, with associates Simon Cooke and Ian Lachow. Advice was also provided on tax matters by partner Jiyeon Lee-Lim, with associate Michael Syku.

Endnotes